KATHMANDU, JULY 20

Nepal on Monday started the inoculation campaign of Johnson and Johnson vaccine, the third COVID-19 jab approved for public use in the country.

Persons with disabilities got jabbed with the Johnson and Johnson vaccine, at Nepal Disabled Association in Kathmandu starting today

The single-shot J&J vaccine provided by the US government to Nepal under COVAX facility came as a big respite for the country which was reeling under shortage of Covid-jabs.

Photos captured by Skanda Gautam for The Himalayan Times.

A man with a disability shows his vaccination card after getting vaccinated with Johnson and Johnson vaccine, the third COVID-19 jab approved for public use in the country, at Nepal Disabled Association in Kathmandu on July 19, 2021, Monday. Photo: Skanda Gautam/THT
A man with a disability shows his vaccination card after getting vaccinated with Johnson and Johnson vaccine, the third COVID-19 jab approved for public use in the country, at Nepal Disabled Association in Kathmandu on July 19, 2021, Monday. Photo: Skanda Gautam/THT

A woman with a disability  get vaccinated with Johnson and Johnson vaccine, the third COVID-19 jab approved for public use in the country, at Nepal Disabled Association in Kathmandu on July 19, 2021, Monday. Photo: Skanda Gautam/THT
A woman with a disability get vaccinated with Johnson and Johnson vaccine, the third COVID-19 jab approved for public use in the country, at Nepal Disabled Association in Kathmandu on July 19, 2021, Monday. Photo: Skanda Gautam/THT

A man with a disability holds his vaccination card after getting vaccinated with Johnson and Johnson vaccine, the third COVID-19 jab approved for public use in the country, at Nepal Disabled Association in Kathmandu on July 19, 2021, Monday. Photo: Skanda Gautam/THT
A man with a disability holds his vaccination card after getting vaccinated with Johnson and Johnson vaccine, the third COVID-19 jab approved for public use in the country, at Nepal Disabled Association in Kathmandu on July 19, 2021, Monday. Photo: Skanda Gautam/THT

A man with a disability  ​get vaccinated with Johnson and Johnson vaccine, the third COVID-19 jab approved for public use in the country, at Nepal Disabled Association in Kathmandu on July 19, 2021, Monday. Photo: Skanda Gautam/THT
A man with a disability ​get vaccinated with Johnson and Johnson vaccine, the third COVID-19 jab approved for public use in the country, at Nepal Disabled Association in Kathmandu on July 19, 2021, Monday. Photo: Skanda Gautam/THT

A health worker administers a dose of Johnson & Johnson COVID-19 vaccine to a woman with a disability at Nepal Disabled Association in Kathmandu on Monday, July 19, 2021. Photo: Skanda Gautam/THT
A health worker administers a dose of Johnson & Johnson COVID-19 vaccine to a woman with a disability at Nepal Disabled Association in Kathmandu on Monday, July 19, 2021. Photo: Skanda Gautam/THT

A woman with a disability waits to receive a dose of Johnson & Johnson COVID-19 vaccine at Nepal Disabled Association in Kathmandu, Nepal on Monday, July 19, 2021. A total of 1.5 million doses of Johnson vaccines were supplied to Nepal by the USA.
A woman with a disability waits to receive a dose of Johnson & Johnson COVID-19 vaccine at Nepal Disabled Association in Kathmandu, Nepal on Monday, July 19, 2021. A total of 1.5 million doses of Johnson vaccines were supplied to Nepal by the USA.

People with disabilities wait to receive a dose of Johnson & Johnson COVID-19 vaccine at Nepal Disabled Association in Kathmandu on Monday, July 19, 2021. Photo: Skanda Gautam/THT
People with disabilities wait to receive a dose of Johnson & Johnson COVID-19 vaccine at Nepal Disabled Association in Kathmandu on Monday, July 19, 2021. Photo: Skanda Gautam/THT

A health worker administers a dose of Johnson & Johnson COVID-19 vaccine at Nepal Disabled Association in Kathmandu on Monday, July 19, 2021. Photo: Skanda Gautam/THT
A health worker administers a dose of Johnson & Johnson COVID-19 vaccine at Nepal Disabled Association in Kathmandu on Monday, July 19, 2021. Photo: Skanda Gautam/THT